CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 966175-966390 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T17372","span":{"begin":0,"end":215},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We analyzed pro-(Bax, Cyt-c, APAF-1) and anti-(Bcl-2) apoptotic proteins in peripheral blood mononuclear cells (PBMNCs) cytosol and mitochondria membranes during GA treatment in relapsing-remitting (RR) MS patients."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T104","span":{"begin":0,"end":215},"obj":"Sentence"}],"text":"We analyzed pro-(Bax, Cyt-c, APAF-1) and anti-(Bcl-2) apoptotic proteins in peripheral blood mononuclear cells (PBMNCs) cytosol and mitochondria membranes during GA treatment in relapsing-remitting (RR) MS patients."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2978","span":{"begin":87,"end":92},"obj":"Body_part"}],"attributes":[{"id":"A2978","pred":"uberon_id","subj":"T2978","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"We analyzed pro-(Bax, Cyt-c, APAF-1) and anti-(Bcl-2) apoptotic proteins in peripheral blood mononuclear cells (PBMNCs) cytosol and mitochondria membranes during GA treatment in relapsing-remitting (RR) MS patients."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5995","span":{"begin":203,"end":205},"obj":"Disease"},{"id":"T18443","span":{"begin":203,"end":205},"obj":"Disease"}],"attributes":[{"id":"A5995","pred":"mondo_id","subj":"T5995","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A87623","pred":"mondo_id","subj":"T18443","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"We analyzed pro-(Bax, Cyt-c, APAF-1) and anti-(Bcl-2) apoptotic proteins in peripheral blood mononuclear cells (PBMNCs) cytosol and mitochondria membranes during GA treatment in relapsing-remitting (RR) MS patients."}